Access Vascular is reinventing venous access with devices that leverage our proprietary bulk hydrophilic biomaterial to improve care, decrease complications and reduce costs. Initially focused on launching our HydroPICC device, a peripherally inserted central catheter with superior material performance that will address a critical need for devices that lower thrombotic risk and adverse events, we are in the early stages of developing hemodialysis, implantable ports and drug delivery devices.